May 15, 2026 04:50AM
May 13, 2026 04:01PM
May 12, 2026 09:31AM
May 12, 2026 09:31AM
May 6, 2026 07:00AM
Mar 30, 2026 07:00AM
Mar 30, 2026 07:00AM Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
Mar 20, 2026 07:00AM
Mar 20, 2026 07:00AM
Mar 20, 2026 07:00AM
Mar 19, 2026 09:00AM
Mar 17, 2026 09:00AM
Mar 13, 2026 09:00AM
Mar 11, 2026 07:01PM Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors
Mar 10, 2026 09:00AM
Mar 9, 2026 04:01PM
Mar 6, 2026 04:40AM
Mar 4, 2026 04:01PM
Feb 20, 2026 07:00AM
Feb 18, 2026 07:00AM
Feb 18, 2026 07:00AM Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
Feb 3, 2026 06:49AM
Feb 2, 2026 07:00AM
Feb 2, 2026 07:00AM
Jan 13, 2026 10:59AM
Jan 9, 2026 07:02AM
Jan 9, 2026 07:00AM
Nov 5, 2025 04:01PM Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Nov 4, 2025 07:00AM
Nov 3, 2025 07:00AM
Oct 30, 2025 07:00AM
Oct 8, 2025 07:00AM
Oct 8, 2025 07:00AM
Sep 4, 2025 07:00AM
Sep 4, 2025 07:00AM Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
Aug 26, 2025 08:07AM
Aug 14, 2025 06:28AM
Aug 14, 2025 06:28AM
Aug 14, 2025 06:01AM
Aug 14, 2025 06:00AM
Aug 11, 2025 04:01PM
Jul 22, 2025 08:53AM Aquestive Therapeutics promotes Korczynski to chief commercial officer
Jul 22, 2025 07:00AM
Jul 15, 2025 07:00AM
Jul 15, 2025 07:00AM
Jun 25, 2025 07:00AM
Jun 17, 2025 06:39AM
Jun 16, 2025 07:02AM
Jun 16, 2025 07:00AM Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions
Jun 2, 2025 08:50AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All